[{"arm_id":"ARM1888","investigation_id":"SDY269","name":"LAIV group 2008","description":"Healthy adults given 2008 LAIV vaccine","participants":null}, {"arm_id":"ARM1889","investigation_id":"SDY269","name":"TIV Group 2008","description":"Healthy adults given 2008 TIV vaccine","participants":null}, {"arm_id":"ARM1891","investigation_id":"SDY270","name":"TIV Group 2009","description":"Healthy adults given 2009 TIV vaccine","participants":null}, {"arm_id":"ARM2102","investigation_id":"SDY296","name":"adult validation cohort","description":"Healthy Adults 2011 - 2012","participants":null}, {"arm_id":"ARM2107","investigation_id":"SDY301","name":"AIRFV 2012-13","description":"Healthy Adults 2012 - 2013","participants":null}, {"arm_id":"ARM2114","investigation_id":"SDY305","name":"TIV group","description":"18-32 year old adults immunized intramuscularly with TIV","participants":null}, {"arm_id":"ARM2126","investigation_id":"SDY311","name":"Group A","description":"18-30 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM2127","investigation_id":"SDY311","name":"Group B","description":"60-79 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM2128","investigation_id":"SDY311","name":"Group C","description":"80-90 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM2129","investigation_id":"SDY312","name":"Group A","description":"18-30 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM2130","investigation_id":"SDY312","name":"Group B","description":"60-79 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM2131","investigation_id":"SDY312","name":"Group C","description":"80-90 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM2137","investigation_id":"SDY315","name":"Group A","description":"18-30 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM2138","investigation_id":"SDY315","name":"Group B","description":"60-79 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM2139","investigation_id":"SDY315","name":"Group C","description":"80-90 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM2350","investigation_id":"SDY400","name":"Young adults 21-30 years old","description":"Young adults 21-30 years old","participants":null}, {"arm_id":"ARM2351","investigation_id":"SDY400","name":"Older adults >= 65 years old","description":"Older adults >= 65 years old","participants":null}, {"arm_id":"ARM2358","investigation_id":"SDY404","name":"Young adults 21-30 years old","description":"Young adults 21-30 years old","participants":null}, {"arm_id":"ARM2359","investigation_id":"SDY404","name":"Older adults >= 65 years old","description":"Older adults >= 65 years old","participants":null}, {"arm_id":"ARM2408","investigation_id":"SDY416","name":"HIPC_PSORIASIS_2010-2011","description":"Adults aged 18-45yrs with chronic plaque psoriasis","participants":null}, {"arm_id":"ARM2510","investigation_id":"SDY472","name":"IM TIV group","description":"18-32 year old adults immunized intramuscularly with TIV","participants":null}, {"arm_id":"ARM2511","investigation_id":"SDY472","name":"ID TIV group","description":"18-32 year old adults immunized intradermally with TIV","participants":null}, {"arm_id":"ARM2594","investigation_id":"SDY514","name":"SLVP018_2009B","description":"18-30 year old monozygotic twins pairs given LAIV3","participants":null}, {"arm_id":"ARM2595","investigation_id":"SDY514","name":"SLVP018_2009C","description":"18-30 year old dizygotic twin pairs given LAIV3","participants":null}, {"arm_id":"ARM2598","investigation_id":"SDY514","name":"SLVP018_2009F","description":"70-100 year old monozygotic or dizygotic twin pairs given IIV3","participants":null}, {"arm_id":"ARM2599","investigation_id":"SDY514","name":"SLVP018_2009G","description":"70-100 year old non-twins given IIV3","participants":null}, {"arm_id":"ARM2601","investigation_id":"SDY515","name":"SLVP018_2010B","description":"18-30 year old monozygotic twins pairs given IIV3","participants":null}, {"arm_id":"ARM2603","investigation_id":"SDY515","name":"SLVP018_2010D","description":"40-59 year old monozygotic twin pairs given IIV3","participants":null}, {"arm_id":"ARM2604","investigation_id":"SDY515","name":"SLVP018_2010E","description":"40-59 year old dizygotic twin pairs given IIV3","participants":null}, {"arm_id":"ARM2613","investigation_id":"SDY519","name":"SLVP018_2011C","description":"18-30 year old dizygotic twin pairs given IIV3","participants":null}, {"arm_id":"ARM2614","investigation_id":"SDY519","name":"SLVP018_2011D","description":"40-64 year old monozygotic twin pairs given IIV3","participants":null}, {"arm_id":"ARM2615","investigation_id":"SDY519","name":"SLVP018_2011E","description":"40-64 year old dizygotic twin pairs given IIV3","participants":null}, {"arm_id":"ARM2619","investigation_id":"SDY520","name":"Young adults 21-30 years old","description":"Young adults 21-30 years old","participants":null}, {"arm_id":"ARM2620","investigation_id":"SDY520","name":"Older adults >= 65 years old","description":"Older adults >= 65 years old","participants":null}, {"arm_id":"ARM2862","investigation_id":"SDY640","name":"Young adults 21-30 years old","description":"Young adults 21-30 years old","participants":null}, {"arm_id":"ARM2863","investigation_id":"SDY640","name":"Older adults >= 65 years old","description":"Older adults >= 65 years old","participants":null}, {"arm_id":"ARM3313","investigation_id":"SDY887","name":"Older","description":"Older participants aged 60 to 89 years, vaccinated with Fluzone","participants":null}, {"arm_id":"ARM4428","investigation_id":"SDY1276","name":"Discovery Cohort; Males 2008-2009 TIV","description":"Males received 2008-2009 trivalent influenza vaccine","participants":null}, {"arm_id":"ARM4431","investigation_id":"SDY1276","name":"Validation Cohort; Females 2008-2009 TIV","description":"Females received 2008-2009 trivalent influenza vaccine","participants":null}, {"arm_id":"ARM466","investigation_id":"SDY63","name":"Young adults 21-30 years old","description":"Young adults 21-30 years old","participants":null}, {"arm_id":"ARM467","investigation_id":"SDY63","name":"Older adults >= 65 years old","description":"Older adults >= 65 years old","participants":null}, {"arm_id":"ARM4685","investigation_id":"SDY1393","name":"Older healthy adults","description":"Healthy adults 65 and older","participants":null}, {"arm_id":"ARM4686","investigation_id":"SDY1393","name":"Younger healthy adults","description":"Healthy adults age 21-40","participants":null}, {"arm_id":"ARM4687","investigation_id":"SDY1393","name":"Frail older adults","description":"Nursing home residents","participants":null}, {"arm_id":"ARM4816","investigation_id":"SDY1465","name":"B","description":"18-30 year old monozygotic twins pairs given LAIV3","participants":null}, {"arm_id":"ARM4818","investigation_id":"SDY1465","name":"D","description":"40-49 year old monozygotic twin pairs given LAIV3","participants":null}, {"arm_id":"ARM4831","investigation_id":"SDY1467","name":"Group B","description":"60-79 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM4832","investigation_id":"SDY1467","name":"Group A","description":"18-30 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM4835","investigation_id":"SDY1468","name":"Group A","description":"18-30 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM4844","investigation_id":"SDY1471","name":"Group A","description":"18-30 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM4847","investigation_id":"SDY1472","name":"Group A","description":"18-30 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM544","investigation_id":"SDY67","name":"healthy adults, 50-74 yo","description":"150 healthy adults, 50-74 yo","participants":null}, {"arm_id":"ARM557","investigation_id":"SDY80","name":"Cohort2","description":"Healthy NIH employees receiving the seasonal flu vaccine","participants":null}, {"arm_id":"ARM642","investigation_id":"SDY112","name":"Group A","description":"18-30 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM643","investigation_id":"SDY112","name":"Group B","description":"60-79 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM644","investigation_id":"SDY112","name":"Group C","description":"80-100 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM645","investigation_id":"SDY113","name":"TIV group","description":"18-30 year old adults immunizaed intramuscularly with Fluzone","participants":null}, {"arm_id":"ARM646","investigation_id":"SDY113","name":"ID TIV group","description":"18-30 year old adults immunized intradermally with Fluzone","participants":null}, {"arm_id":"ARM647","investigation_id":"SDY113","name":"LAIV group","description":"18-30 year old adults immunized intranasally with FluMist","participants":null}, {"arm_id":"ARM773","investigation_id":"SDY180","name":"Study group 1 2009-2010 Fluzone","description":"2009-2010 Fluzone vaccine, Samples at Day -7,0,1,3,7,10,14,21,28","participants":null}, {"arm_id":"ARM776","investigation_id":"SDY180","name":"Study group 2 2009-2010 Fluzone","description":"2009-2010 Fluzone vaccine, Samples at Hour -168,0,1.5,3,6,9,12,15,24,36,48","participants":null}, {"arm_id":"ARM777","investigation_id":"SDY180","name":"Study group 2 Pneunomax23","description":"Pneunomax23, Samples at Hour -168,0,1.5,3,6,9,12,15,24,36,48","participants":null}, {"arm_id":"ARM779","investigation_id":"SDY180","name":"Study group 3 2009-2010 Fluzone","description":"2009-2010 Fluzone vaccine, Samples at Day 0,1,28","participants":null}, {"arm_id":"ARM855","investigation_id":"SDY202","name":"18-32 year old immunized adults","description":"18-32 year old adults immunized intramuscularly with inactivated 2009 pandemic influenza A/H1N1 (pH1N1) vaccine","participants":null}, {"arm_id":"ARM856","investigation_id":"SDY202","name":"60-69 year old immunized adults","description":"60-69 year old adults immunized intramuscularly with inactivated 2009 pandemic influenza A/H1N1 (pH1N1) vaccine","participants":null}, {"arm_id":"ARM857","investigation_id":"SDY202","name":">69 year old immunized adults","description":">69 year old adults immunized intramuscularly with inactivated 2009 pandemic influenza A/H1N1 (pH1N1) vaccine","participants":null}, {"arm_id":"ARM894","investigation_id":"SDY212","name":"Cohort_1","description":"Young participants aged 20 to 30 years, vaccinated with Fluzone","participants":null}, {"arm_id":"ARM895","investigation_id":"SDY212","name":"Cohort_2","description":"Older participants aged 60 to 89 years, vaccinated with Fluzone","participants":null}, {"arm_id":"ARM926","investigation_id":"SDY224","name":"TIV 2010","description":"Subjects receiving TIV seasonal vaccine in the 2010-2011 influenza season","participants":null}, {"arm_id":"ARM2596","investigation_id":"SDY514","name":"SLVP018_2009D","description":"40-49 year old monozygotic twin pairs given LAIV3","participants":null}, {"arm_id":"ARM2602","investigation_id":"SDY515","name":"SLVP018_2010C","description":"18-30 year old dizygotic twin pairs given IIV3","participants":null}, {"arm_id":"ARM2605","investigation_id":"SDY515","name":"SLVP018_2010F","description":"70-100 year old monozygotic twins randomly assigned within pair to receive either IIV3 or High-Dose IIV3","participants":null}, {"arm_id":"ARM2612","investigation_id":"SDY519","name":"SLVP018_2011B","description":"18-30 year old monozygotic twins pairs given IIV3","participants":null}, {"arm_id":"ARM2616","investigation_id":"SDY519","name":"SLVP018_2011F","description":"65-100 year old monozygotic twins randomly assigned within pair to receive either IIV3 or High-Dose IIV3","participants":null}, {"arm_id":"ARM3312","investigation_id":"SDY887","name":"Young","description":"Young participants aged 20 to 30 years, vaccinated with Fluzone","participants":null}, {"arm_id":"ARM457","investigation_id":"SDY61","name":"TIV Group 2007","description":"Healthy adults given 2007 TIV vaccine","participants":null}, {"arm_id":"ARM4820","investigation_id":"SDY1465","name":"F","description":"70-100 year old monozygotic or dizygotic twin pairs given IIV3","participants":null}, {"arm_id":"ARM4834","investigation_id":"SDY1468","name":"Group B","description":"60-79 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM4837","investigation_id":"SDY1469","name":"Group B","description":"60-79 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM2597","investigation_id":"SDY514","name":"SLVP018_2009E","description":"40-49 year old dizygotic twin pairs given LAIV3","participants":null}, {"arm_id":"ARM4833","investigation_id":"SDY1467","name":"Group C","description":"80-100 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM4836","investigation_id":"SDY1468","name":"Group C","description":"80-100 year old adults immunized intramuscularly with Fluzone (TIV)","participants":null}, {"arm_id":"ARM4866","investigation_id":"SDY1479","name":"IM TIV group","description":"18-32 year old adults immunized intramuscularly with TIV","participants":null}, {"arm_id":"ARM2115","investigation_id":"SDY305","name":"ID TIV group","description":"18-32 year old adults immunized intradermally with TIV","participants":null}, {"arm_id":"ARM4815","investigation_id":"SDY1465","name":"A","description":"8-17 year old monozygotic twins randomly assigned within pair to receive either IIV3 or LAIV3","participants":null}, {"arm_id":"ARM2875","investigation_id":"SDY645","name":"JDM_ 2014-2015","description":"TIV Vaccine","participants":null}, {"arm_id":"2016_UGA_Standard_Fluzone","investigation_id":"2016_UGA","name":"2016 UGA Standard Fluzone","description":"2016 UGA Standard Fluzone","participants":null}, {"arm_id":"2016_UGA_High_Dose_Fluzone","investigation_id":"2016_UGA","name":"2016 UGA High Dose Fluzone","description":"2016 UGA High Dose Fluzone","participants":null}, {"arm_id":"2017_UGA_Standard_Fluzone","investigation_id":"2017_UGA","name":"2017 UGA Standard Fluzone","description":"2017 UGA Standard Fluzone","participants":null}, {"arm_id":"2017_UGA_High_Dose_Fluzone","investigation_id":"2017_UGA","name":"2017 UGA High Dose Fluzone","description":"2017 UGA High Dose Fluzone","participants":null}, {"arm_id":"2018_UGA_Standard_Fluzone","investigation_id":"2018_UGA","name":"2018 UGA Standard Fluzone","description":"2018 UGA Standard Fluzone","participants":null}, {"arm_id":"2018_UGA_High_Dose_Fluzone","investigation_id":"2018_UGA","name":"2018 UGA High Dose Fluzone","description":"2018 UGA High Dose Fluzone","participants":null}, {"arm_id":"2019_UGA_Standard_Fluzone","investigation_id":"2019_UGA","name":"2019 UGA Standard Fluzone","description":"2019 UGA Standard Fluzone","participants":null}, {"arm_id":"2019_UGA_High_Dose_Fluzone","investigation_id":"2019_UGA","name":"2019 UGA High Dose Fluzone","description":"2019 UGA High Dose Fluzone","participants":null}, {"arm_id":"2020_UGA_Standard_Fluzone","investigation_id":"2020_UGA","name":"2020 UGA Standard Fluzone","description":"2020 UGA Standard Fluzone","participants":null}, {"arm_id":"2020_UGA_High_Dose_Fluzone","investigation_id":"2020_UGA","name":"2020 UGA High Dose Fluzone","description":"2020 UGA High Dose Fluzone","participants":null}, {"arm_id":"2021_UGA_Standard_Fluzone","investigation_id":"2021_UGA","name":"2021 UGA Standard Fluzone","description":"2021 UGA Standard Fluzone","participants":null}, {"arm_id":"2021_UGA_High_Dose_Fluzone","investigation_id":"2021_UGA","name":"2021 UGA High Dose Fluzone","description":"2021 UGA High Dose Fluzone","participants":null}, {"arm_id":"2022_UGA_Standard_Fluzone","investigation_id":"2022_UGA","name":"2022 UGA Standard Fluzone","description":"2022 UGA Standard Fluzone","participants":null}, {"arm_id":"2022_UGA_High_Dose_Fluzone","investigation_id":"2022_UGA","name":"2022 UGA High Dose Fluzone","description":"2022 UGA High Dose Fluzone","participants":null}, {"arm_id":"2023_UGA_Standard_Fluzone","investigation_id":"2023_UGA","name":"2023 UGA Standard Fluzone","description":"2023 UGA Standard Fluzone","participants":null}, {"arm_id":"2023_UGA_High_Dose_Fluzone","investigation_id":"2023_UGA","name":"2023 UGA High Dose Fluzone","description":"2023 UGA High Dose Fluzone","participants":null}]